Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Efficacy of Artesunate for Treatment of Cytomegalovirus Reactivations in Allogeneic Haematopoietic Stem Cell Transplant Recipients Who Are Intolerant/Unsuitable for Ganciclovir Therapy

Ramnath K Shenoy, MD, Anant Gokarn, MD, Anup Toshniwal, MDDM, Siddhesh Arun Kalantri, MD, Akanksha Chichra, DNB, Sachin Punatar, MBBS,MDDM MDcal Oncology, Avinash Bonda, MD DM, Lingaraj Nayak, MDDM MDcal Oncology, Libin J Mathew, Vivek Bhat, MD, Sanjay Biswas, MD, Rohini Kelkar, MD, Navin Khattry, MD DM MDcal Oncology

Blood (2019) 134 (Supplement_1): 4506.

https://doi.org/10.1182/blood-2019-128766

Published: 2019

Journal Articles

Pharmacotherapy Interventions and Barriers to Treatment of Sickle Cell Disease in Ibadan, Nigeria

Ijele Adimora, Titilola S. Akingbola, MBBS, FWACP, Frederick Lansigan, MD, Jack van Hoff, MD

Blood (2018) 132 (Supplement 1): 3523.

https://doi.org/10.1182/blood-2018-99-118384

Published: 2018

Journal Articles

The 3-Drug Combination Treatment ART838, ABT199 Plus Sorafenib Is Effective Against AML Xenografts, Possibly Via Cooperative Targeting of MCL1

Blake S Moses, PhD, Jennifer Fox, PhD, Xiaochun Chen, PhD, Samantha McCullough, BS, Sang Ngoc Tran, BA, Allison Kirkpatrick, BS, Kalyani Kumar, BS, Jeffrey W. Tyner, PhD, Gary H. Posner, PhD, Curt I. Civin, MD

Blood (2018) 132 (Supplement 1): 4044.

https://doi.org/10.1182/blood-2018-99-113040

Published: 2018

Journal Articles

Nrf2 Regulates Sensitivity of Leukemias to Artemisinins

Jennifer Bai, BA, Xiaochun Chen, PhD, Curt I. Civin, MD

Blood (2016) 128 (22): 2324.

https://doi.org/10.1182/blood.V128.22.2324.2324

Published: 2016

Journal Articles

Mefloquine Effectively Targets Blast Phase Chronic Myeloid Leukemia through Inducing Oxidative Stress and Lysosomal Disruption

Wei Xiang, PhD, Yi Hui Lam, Collin Sng, May Anne Cheong, MBBS, MRCP, Hein Than, MD, William YK Hwang, MBBS, MRCP, FRCP, Charles Chuah

Blood (2016) 128 (22): 5426.

https://doi.org/10.1182/blood.V128.22.5426.5426

Published: 2016

Journal Articles

Idarucizumab, a Specific Antidote for Dabigatran, Cross-Reacts with Melagatran and May Also Interact with Other Benzamidine-Containing Compounds

Jawed Fareed, PhD, Larissa Reikensmeyer, Amanda Walborn, BS, Debra Hoppensteadt, PhD, Jeanine M. Walenga, PhD, Eduardo Ramacciotti, MD, Schuharazad Abro, MD, Walter Jeske, PhD, Olivia Bouchard, Ismail Elalamy, MD PhD

Blood (2016) 128 (22): 3836.

https://doi.org/10.1182/blood.V128.22.3836.3836

Published: 2016

Journal Articles

Synergistic Targeting of Protein Translation and Inhibition of NOTCH Signaling in T-ALL

Marta Sanchez-Martin, PhD, Alberto Ambesi-Impiombato, MDPhD, Luyao Xu, Yue Qin, Daniel Herranz, PhD, Mukesh Bansal, PhD, Tiziana Girardi, Kim De Keersmaecker, Andrea Califano, PhD, Adolfo A. Ferrando, MD PhD

Blood (2015) 126 (23): 3719.

https://doi.org/10.1182/blood.V126.23.3719.3719

Published: 2015

Journal Articles

Autophagy Inhibition Overcomes Resistance to Cytosine Arabinoside in Acute Myeloid Leukemia Cells through Inducing Autophagic Cell Death and Intrinsic Pathway Apoptosis

Yundeok Kim, MD, Ju-In Eom, Hoi-Kyung Jeung, Jieun Jang, MD, Jin Seok Kim, June-Won Cheong, MD,PhD, Young Sam Kim, Yoo Hong Min, MD,PhD

Blood (2014) 124 (21): 909.

https://doi.org/10.1182/blood.V124.21.909.909

Published: 2014

Journal Articles

Senicapoc, a Gardos Channel Inhibitor Developed to Treat Sickle Cell Disease, Exhibits Antimalarial Activity

Venee N. Tubman, MD MMSc, Pedro Mejia, PhD, Boris E. Shmukler, PhD, Seth L. Alper, MD PhD, James R. Mitchell, PhD, Carlo Brugnara, MD, Manoj T. Duraisingh, PhD

Blood (2014) 124 (21): 743.

https://doi.org/10.1182/blood.V124.21.743.743

Published: 2014

Journal Articles

Platelet Factor 4 Enables Platelets to Suppress Early Parasite Growth in a Mouse Model of Blood Stage Malarial Infection

Brendan John McMorran, BSc (Hons), PhD, Bernadette Pedersen, Gaetan Burgio, Simon J Foote, MBBS, PhD

Blood (2014) 124 (21): 1433.

https://doi.org/10.1182/blood.V124.21.1433.1433

Published: 2014

Journal Articles

Erythropoietic Protoporphyric Red Blood Cells Are Resistant to the Growth of Malarial Parasites

Brendan John McMorran, BSc (Hons), PhD, Clare M Smith, BSc (Hons), PhD, Ante Jerkovic, Hervé Puy, MD PhD, Ingrid Winship, Jean-Charles Deybach, Laurent Gouya, Giel van Dooren, Christopher Dean Goodman, Angelika Sturm, Hana Manceau, Geoffrey Ian McFadden, Peter David, Odile Mercereau-Puijalon, Gaetan Burgio, Simon J Foote, MBBS, PhD

Blood (2014) 124 (21): 2670.

https://doi.org/10.1182/blood.V124.21.2670.2670

Published: 2014

Journal Articles

The Antimalarial Agent Artesunate Exerts Its Antimyeloma Activity By Affecting The Mitochondria and The Reactive Oxygen Status Of The Myeloma Cells and Its Efficacy Depends On Intracellular Bivalent Iron Levels

Xenofon Papanikolaou, MD, Sarah K. Johnson, PhD, Tarun K. Garg, PhD, Erming Tian, PhD, Ruslana Tytarenko, Bart Barlogie, MD, PhD, Joshua Epstein, DSc, Christoph Heuck, MD

Blood (2013) 122 (21): 4444.

https://doi.org/10.1182/blood.V122.21.4444.4444

Published: 2013

Journal Articles

Disseminated Tuberculosis with Hemophagocytic Lymphohistiocytosis (HLH)

Suparna Ajit Rao, Tarun K. Dutta, MD, Rakesh V Naik, Aishwarya Krishnamurthy, Vinod K. Viswanath

Blood (2012) 120 (21): 4686.

https://doi.org/10.1182/blood.V120.21.4686.4686

Published: 2012

Journal Articles

A Potential Antithrombotic Trick for an Old Drug: Quinine Inhibits the Binding of Antiphospholipid Antibody-β2-Glycoprotein I Immune Complexes to Phospholipid Bilayers in Vitro

Ervis Bezati, Xiao Xuan Wu, MD, Jacob H. Rand, MD

Blood (2012) 120 (21): 3423.

https://doi.org/10.1182/blood.V120.21.3423.3423

Published: 2012

Journal Articles

The Antimalarial Agent Artesunate Overcomes Bortezomib Resistance in Myeloma Cell Lines Through Non-Caspase Mediated Apoptosis

Xenofon Papanikolaou, MD, Ruslana Tytarenko, Tarun K. Garg, PhD, Sarah K. Johnson, PhD, Erming Tian, Senu Apewokin, MD, Bart Barlogie, MD, Joshua Epstein, DSc, Christoph Heuck, MD

Blood (2012) 120 (21): 4015.

https://doi.org/10.1182/blood.V120.21.4015.4015

Published: 2012

Journal Articles

Nanofiber-Based Expansion and Differentiation Technology for High-Volume Ex Vivo Production of Reticulocytes for P. Vivax Malaria Research

Hong Wang, PhD, Adam M Sorkin, PE, Ramasamy Sakthivel, PhD

Blood (2011) 118 (21): 2357.

https://doi.org/10.1182/blood.V118.21.2357.2357

Published: 2011

Journal Articles

PF4-Related Kinocidins Mediate Plasmodicidal Activity of Platelets

Anish V Sharda, MBBS, MPH, Gerhard Johnson, MD

Blood (2011) 118 (21): 1140.

https://doi.org/10.1182/blood.V118.21.1140.1140

Published: 2011

Journal Articles

Lysosomal Disruption Selectively Targets Leukemia Cells and Leukemia Stem Cells Through A Mechanism Related to Increased Reactive Oxygen Species Production

Blood (2011) 118 (21): 61.

https://doi.org/10.1182/blood.V118.21.61.61

Published: 2011

Journal Articles

Digestive vacuoles of Plasmodium falciparum are selectively phagocytosed by and impair killing function of polymorphonuclear leukocytes

Prasad Dasari, Karina Reiss, Klaus Lingelbach, Stefan Baumeister, Ralph Lucius, Rachanee Udomsangpetch, Sebastian Chakrit Bhakdi, Sucharit Bhakdi

Blood (2011) 118 (18): 4946–4956.

https://doi.org/10.1182/blood-2011-05-353920

Published: 2011

Journal Articles

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

Jacob H. Rand, Xiao-Xuan Wu, Anthony S. Quinn, Anthony W. Ashton, Pojen P. Chen, James J. Hathcock, Harry A. M. Andree, Douglas J. Taatjes

Blood (2010) 115 (11): 2292–2299.

https://doi.org/10.1182/blood-2009-04-213520

Published: 2010

NARROW

Efficacy of Artesunate for Treatment of Cytomegalovirus Reactivations in Allogeneic Haematopoietic Stem Cell Transplant Recipients Who Are Intolerant/Unsuitable for Ganciclovir Therapy

Pharmacotherapy Interventions and Barriers to Treatment of Sickle Cell Disease in Ibadan, Nigeria

The 3-Drug Combination Treatment ART838, ABT199 Plus Sorafenib Is Effective Against AML Xenografts, Possibly Via Cooperative Targeting of MCL1

Nrf2 Regulates Sensitivity of Leukemias to Artemisinins

Mefloquine Effectively Targets Blast Phase Chronic Myeloid Leukemia through Inducing Oxidative Stress and Lysosomal Disruption

Idarucizumab, a Specific Antidote for Dabigatran, Cross-Reacts with Melagatran and May Also Interact with Other Benzamidine-Containing Compounds

Synergistic Targeting of Protein Translation and Inhibition of NOTCH Signaling in T-ALL

Autophagy Inhibition Overcomes Resistance to Cytosine Arabinoside in Acute Myeloid Leukemia Cells through Inducing Autophagic Cell Death and Intrinsic Pathway Apoptosis

Senicapoc, a Gardos Channel Inhibitor Developed to Treat Sickle Cell Disease, Exhibits Antimalarial Activity

Platelet Factor 4 Enables Platelets to Suppress Early Parasite Growth in a Mouse Model of Blood Stage Malarial Infection

Erythropoietic Protoporphyric Red Blood Cells Are Resistant to the Growth of Malarial Parasites

The Antimalarial Agent Artesunate Exerts Its Antimyeloma Activity By Affecting The Mitochondria and The Reactive Oxygen Status Of The Myeloma Cells and Its Efficacy Depends On Intracellular Bivalent Iron Levels

Disseminated Tuberculosis with Hemophagocytic Lymphohistiocytosis (HLH)

A Potential Antithrombotic Trick for an Old Drug: Quinine Inhibits the Binding of Antiphospholipid Antibody-β2-Glycoprotein I Immune Complexes to Phospholipid Bilayers in Vitro

The Antimalarial Agent Artesunate Overcomes Bortezomib Resistance in Myeloma Cell Lines Through Non-Caspase Mediated Apoptosis

Nanofiber-Based Expansion and Differentiation Technology for High-Volume Ex Vivo Production of Reticulocytes for P. Vivax Malaria Research

PF4-Related Kinocidins Mediate Plasmodicidal Activity of Platelets

Lysosomal Disruption Selectively Targets Leukemia Cells and Leukemia Stem Cells Through A Mechanism Related to Increased Reactive Oxygen Species Production

Digestive vacuoles of Plasmodium falciparum are selectively phagocytosed by and impair killing function of polymorphonuclear leukocytes

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only